Culmination Bio Raises $10M to Bring Longitudinal Health Data to Biopharma
HIT Consultant
NOVEMBER 30, 2023
The challenge originates from the time-consuming task of acquiring longitudinal biological and clinical patient data, a process that takes life sciences and biotech companies months to complete. “With support from our investors, Culmination Bio is raising the bar for healthcare innovation,” said Lincoln Nadauld, MD, Ph.D.,
Let's personalize your content